Trilinolein cream to prevent eczema flare-ups
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a cream called trilinolein to see if it can prevent eczema from coming back in people whose skin is currently clear or nearly clear. If you have had moderate-to-severe eczema and are in a quiet phase, this treatment might help you stay symptom-free longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 to 75 years old.
- You have been diagnosed with atopic dermatitis (eczema).
- Your eczema has been moderate to severe in the past, but is now mild (score of 1 or less) for at least 2 weeks.
- You have not used certain eczema treatments recently (for example, certain injectable or oral medications).
- You are not currently having a flare-up with oozing or infected skin.
- You are willing to follow the study plan and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an ointment called QLM3003 is safe and helps adults with mild to moderate atopic dermatitis (eczema). It may be a new treatment option for people whose eczema affects small areas of skin.
This study tests an investigational shot (tralokinumab) plus a steroid cream for children with moderate-to-severe eczema that hasn't been controlled by creams alone. It aims to see if the combination is safe and works better than the cream alone.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
This trial tests a new drug called IBI3002 in people with moderate-to-severe atopic dermatitis (eczema) to see if it is safe and tolerable. It may help reduce skin inflammation and itching.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.